Why steroids not recommended in Singapore treatment of COVID-19 patients despite 'major breakthrough' in UK

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Dexamethasone is the first drug to improve survival in COVID-19 patients, a team from Oxford University found, and is widely available and ...

The findings were hailed as a “major breakthrough” in the fight against the disease, with the inexpensive drug normally used to treat a range of allergic reactions, such as rheumatoid arthritis and asthma.

"Steroids will also delay viral clearance and as such were recommended to be avoided unless there are other reasons for their use such as exacerbation of asthma, chronic obstructive lung disease and refractory septic shock in COVID-19 patients," Dr Vasoo told CNA. "Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result," said Peter Horby, professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford.Britain's Health Secretary Matt Hancock said the country's patients would start to receive the drug.

Doctors in some parts of the world, such as Denmark and the US, have started prescribing the steroid to COVID-19 patients.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

French COVID-19 deaths rise by 19 to 29,633The number of deaths in France from COVID-19 has risen by 19 from Friday to stand at 29,633, the health ministry said on Saturday.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »